Petco Health & Wellness Company, Inc.
WOOF Nasdaq Retail-Retail Stores, Nec Financials FY2019–FY2025
Revenue
Total sales reported in the income statement.
$6.0B
2.5%
vs prior year
Operating margin
Operating income as a share of revenue.
2.0%
1.9 pts
Net income
Profit after all expenses, interest and tax.
$9.1M
Free cash flow
Cash from operations minus capital spending.
$187M
276.3%
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
3.3%
3.0 pts
Market cap
Last close times the latest diluted share count, so it is approximate.
—
P/E
Last close divided by diluted earnings per share over the last four quarters.
—
On $0.10 EPS (TTM)
What Petco Health & Wellness Company, Inc. does
No business description yet.
- Legal name
- Petco Health & Wellness Company, Inc.
- Fiscal year ends
- January 31, 2026
- Latest annual report
- 10-K · Mar 13, 2026
- Accession · CIK
- 0001193125-26-106114
0001826470
Revenue and margins
Petco Health & Wellness Company, Inc. had $6.0B of revenue in fiscal 2025, down 2.5% on the year before.
FY19
Revenue $4.4B
FY20
Revenue $4.9B
FY21
Revenue $5.8B
FY22
Revenue $6.0B
FY23
Revenue $6.3B
FY24
Revenue $6.1B
FY25
Revenue $6.0B
Q3 '23
Revenue $1.5B
Q4 '23
Revenue $1.7B
Q1 '24
Revenue $1.5B
Q2 '24
Revenue $1.5B
Q3 '24
Revenue $1.5B
Q4 '24
Revenue $1.6B
Q1 '25
Revenue $1.5B
Q2 '25
Revenue $1.5B
Q3 '25
Revenue $1.5B
Q4 '25
Revenue $1.5B
Q1 '26
Revenue $1.5B
Q2 '26
Revenue $1.5B
FY19
Gross 43.0%
Operating 2.5%
Net −2.2%
FCF −1.1%
FY20
Gross 42.8%
Operating 4.0%
Net −0.5%
FCF 2.2%
FY21
Gross 41.8%
Operating 4.6%
Net 2.8%
FCF 2.1%
FY22
Gross 40.2%
Operating 3.7%
Net 1.5%
FCF 1.1%
FY23
Gross 37.6%
Operating −18.9%
Net −20.5%
FCF −0.2%
FY24
Gross 38.0%
Operating 0.1%
Net −1.7%
FCF 0.8%
FY25
Gross 38.7%
Operating 2.0%
Net 0.2%
FCF 3.1%
Gross
Operating
Net
FCF
Q3 '23
Gross 36.8%
Operating −82.5%
Net −83.1%
FCF −1.9%
Q4 '23
Gross 36.2%
Operating 0.0%
Net −1.3%
FCF −0.1%
Q1 '24
Gross 37.8%
Operating −1.1%
Net −3.0%
FCF −2.7%
Q2 '24
Gross 38.1%
Operating 0.2%
Net −1.6%
FCF 2.8%
Q3 '24
Gross 38.1%
Operating 0.3%
Net −1.1%
FCF −0.7%
Q4 '24
Gross 38.0%
Operating 1.1%
Net −0.9%
FCF 3.8%
Q1 '25
Gross 38.2%
Operating 1.1%
Net −0.8%
FCF −2.9%
Q2 '25
Gross 39.3%
Operating 2.9%
Net 0.9%
FCF 3.6%
Q3 '25
Gross 38.9%
Operating 2.0%
Net 0.6%
FCF 4.1%
Q4 '25
Gross 38.3%
Operating 2.1%
Net −0.2%
FCF 7.7%
Q1 '26
Gross 38.4%
Operating 1.6%
Net −1.0%
FCF −4.6%
Q2 '26
Gross 39.7%
Operating 3.2%
Net 2.6%
FCF 8.7%
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY19
Net income −$95.9M
FY20
Net income −$26.5M
FY21
Net income $164M
FY22
Net income $90.8M
FY23
Net income −$1.3B
FY24
Net income −$102M
FY25
Net income $9.1M
Q3 '23
Net income −$1.2B
Q4 '23
Net income −$22.6M
Q1 '24
Net income −$46.5M
Q2 '24
Net income −$24.8M
Q3 '24
Net income −$16.7M
Q4 '24
Net income −$13.8M
Q1 '25
Net income −$11.7M
Q2 '25
Net income $14.0M
Q3 '25
Net income $9.3M
Q4 '25
Net income −$2.6M
Q1 '26
Net income −$15.1M
Q2 '26
Net income $38.7M
FY19
Diluted EPS −$0.46
FY20
Diluted EPS −$0.13
FY21
Diluted EPS $0.62
FY22
Diluted EPS $0.34
FY23
Diluted EPS −$4.78
FY24
Diluted EPS −$0.37
FY25
Diluted EPS $0.03
Q3 '23
Diluted EPS −$4.63
Q4 '23
Diluted EPS −$0.09
Q1 '24
Diluted EPS −$0.17
Q2 '24
Diluted EPS −$0.09
Q3 '24
Diluted EPS −$0.06
Q4 '24
Diluted EPS −$0.05
Q1 '25
Diluted EPS −$0.04
Q2 '25
Diluted EPS $0.05
Q3 '25
Diluted EPS $0.03
Q4 '25
Diluted EPS −$0.01
Q1 '26
Diluted EPS −$0.05
Q2 '26
Diluted EPS $0.13
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY19
Return on capital —
Return on equity −17.1%
Return on assets —
FY20
Return on capital 4.3%
Return on equity −2.0%
Return on assets −0.4%
FY21
Return on capital 5.3%
Return on equity 7.6%
Return on assets 2.6%
FY22
Return on capital 4.0%
Return on equity 3.9%
Return on assets 1.4%
FY23
Return on capital −35.2%
Return on equity −71.8%
Return on assets −21.4%
FY24
Return on capital 0.2%
Return on equity −8.9%
Return on assets −1.9%
FY25
Return on capital 3.3%
Return on equity 0.8%
Return on assets 0.2%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was $187M in fiscal 2025, 3.1% of revenue. Cash from operations minus capital spending.
FY19
Free cash flow −$46.6M
FY20
Free cash flow $109M
FY21
Free cash flow $119M
FY22
Free cash flow $68.0M
FY23
Free cash flow −$9.9M
FY24
Free cash flow $49.7M
FY25
Free cash flow $187M
Q3 '23
Free cash flow −$28.1M
Q4 '23
Free cash flow −$2.0M
Q1 '24
Free cash flow −$41.1M
Q2 '24
Free cash flow $42.0M
Q3 '24
Free cash flow −$10.3M
Q4 '24
Free cash flow $59.0M
Q1 '25
Free cash flow −$43.9M
Q2 '25
Free cash flow $53.8M
Q3 '25
Free cash flow $60.6M
Q4 '25
Free cash flow $116M
Q1 '26
Free cash flow −$69.1M
Q2 '26
Free cash flow $130M
FY19
Cash from operations $110M
Capital spending $157M
FY20
Cash from operations $269M
Capital spending $160M
FY21
Cash from operations $358M
Capital spending $239M
FY22
Cash from operations $346M
Capital spending $278M
FY23
Cash from operations $216M
Capital spending $226M
FY24
Cash from operations $178M
Capital spending $128M
FY25
Cash from operations $314M
Capital spending $127M
Cash from operations
Capital spending
Q3 '23
Cash from operations $34.4M
Capital spending $62.5M
Q4 '23
Cash from operations $47.0M
Capital spending $49.1M
Q1 '24
Cash from operations −$8.4M
Capital spending $32.6M
Q2 '24
Cash from operations $69.4M
Capital spending $27.4M
Q3 '24
Cash from operations $20.7M
Capital spending $31.0M
Q4 '24
Cash from operations $96.0M
Capital spending $36.9M
Q1 '25
Cash from operations −$15.5M
Capital spending $28.4M
Q2 '25
Cash from operations $85.9M
Capital spending $32.1M
Q3 '25
Cash from operations $90.1M
Capital spending $29.4M
Q4 '25
Cash from operations $154M
Capital spending $37.1M
Q1 '26
Cash from operations −$31.0M
Capital spending $38.2M
Q2 '26
Cash from operations $162M
Capital spending $31.6M
Cash from operations
Capital spending
Dividends, buybacks and share count
Petco Health & Wellness Company, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 4.7%.
FY19
Dividends —
Buybacks —
FY20
Dividends —
Buybacks —
FY21
Dividends —
Buybacks —
FY22
Dividends —
Buybacks —
FY23
Dividends —
Buybacks —
FY24
Dividends —
Buybacks —
FY25
Dividends —
Buybacks —
Dividends
Buybacks
FY19
Diluted shares 0.00B
FY20
Diluted shares 0.00B
FY21
Diluted shares 0.00B
FY22
Diluted shares 0.27B
FY23
Diluted shares 0.27B
FY24
Diluted shares 0.27B
FY25
Diluted shares 0.29B
Balance sheet
Cash, debt and the ratios that show how comfortably Petco Health & Wellness Company, Inc. can carry it.
FY19
Cash $155M
Debt —
FY20
Cash $111M
Debt $1.6B
FY21
Cash $212M
Debt $1.7B
FY22
Cash $202M
Debt $1.7B
FY23
Cash $125M
Debt $1.6B
FY24
Cash $166M
Debt $1.6B
FY25
Cash $257M
Debt $1.5B
Cash
Debt
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $212M | $202M | $125M | $166M | $257M |
| Debt incl. finance leases | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B |
| Net debt / EBITDA | 3.4x | 3.5x | — | 6.6x | 3.9x |
| Debt / equity | 0.7x | 0.7x | 1.3x | 1.4x | 1.3x |
| Interest coverage | 3.4x | 2.2x | −7.8x | 0.0x | 0.9x |
| Current ratio | 1.0x | 1.0x | 0.9x | 0.9x | 0.9x |
| Quick ratio | 0.4x | 0.4x | 0.2x | 0.3x | 0.4x |
| Total assets | $6.5B | $6.6B | $5.4B | $5.2B | $5.2B |
| Total liabilities | $4.2B | $4.2B | $4.2B | $4.1B | $4.0B |
| Shareholders' equity | $2.3B | $2.4B | $1.2B | $1.1B | $1.2B |
| Net debt (− = net cash) | $1.5B | $1.5B | $1.5B | $1.4B | $1.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ | ✕ | ✕ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | ✓ | ✓ | ✕ | ✕ | ✓ |
| Current ratio rose | — | — | ✓ | ✕ | ✕ | ✕ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ |
| Revenue rose relative to assets | — | — | ✓ | ✓ | ✓ | ✓ | ✕ |
| F-score | — / 3 | — / 5 | 7 / 9 | 5 / 9 | 3 / 9 | 5 / 9 | 7 / 9 |
| Accruals ratio | — | −4.9% | −3.1% | −3.9% | −25.0% | −5.3% | −5.9% |
| Altman Z'' | — | 0.64 | 0.93 | 0.93 | −2.02 | −0.63 | −0.40 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $4.4B | $4.9B | $5.8B | $6.0B | $6.3B | $6.1B | $6.0B |
| Gross profit | $1.9B | $2.1B | $2.4B | $2.4B | $2.4B | $2.3B | $2.3B |
| Operating income | $111M | $194M | $266M | $226M | −$1.2B | $7.1M | $120M |
| Interest expense | $253M | $219M | $77.4M | $102M | $151M | $144M | $131M |
| Pretax income | −$142M | −$41.6M | $202M | $112M | −$1.3B | −$109M | $15.3M |
| Income tax | −$35.7M | −$3.3M | $53.5M | $35.3M | −$27.6M | −$7.5M | $6.3M |
| Net income | −$95.9M | −$26.5M | $164M | $90.8M | −$1.3B | −$102M | $9.1M |
| Diluted EPS | −$0.46 | −$0.13 | $0.62 | $0.34 | −$4.78 | −$0.37 | $0.03 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.27B | 0.27B | 0.27B | 0.29B |
| Cash flow | |||||||
| Cash from operations | $110M | $269M | $358M | $346M | $216M | $178M | $314M |
| Capital expenditure | $157M | $160M | $239M | $278M | $226M | $128M | $127M |
| Free cash flow | −$46.6M | $109M | $119M | $68.0M | −$9.9M | $49.7M | $187M |
| Depreciation and amortization | $174M | $175M | $172M | $194M | $204M | $209M | $197M |
| Stock-based compensation | $9.5M | $12.9M | $49.3M | $60.8M | $81.9M | $50.2M | $32.7M |
| Acquisitions | $2.8M | — | $4.3M | $9.6M | $6.7M | $0.6M | — |
| Balance sheet | |||||||
| Cash and short-term investments | $155M | $111M | $212M | $202M | $125M | $166M | $257M |
| Total debt | — | $1.6B | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B |
| Finance lease liabilities | — | — | $29.8M | $29.4M | $24.2M | $13.8M | $9.7M |
| Current assets | — | $778M | $1.1B | $1.0B | $952M | $974M | $1.0B |
| Current liabilities | — | $875M | $1.1B | $1.0B | $1.1B | $1.1B | $1.1B |
| Inventory | — | $539M | $675M | $652M | $685M | $653M | $590M |
| Property and equipment, net | — | $628M | $727M | $803M | $816M | $725M | $656M |
| Goodwill | $2.2B | $2.2B | $2.2B | $2.2B | $980M | $980M | $980M |
| Intangible assets | — | $0.7M | — | — | — | — | — |
| Total assets | — | $6.1B | $6.5B | $6.6B | $5.4B | $5.2B | $5.2B |
| Total liabilities | — | $4.0B | $4.2B | $4.2B | $4.2B | $4.1B | $4.0B |
| Preferred stock | — | $0.0M | — | — | — | — | — |
| Shareholders' equity | $561M | $2.1B | $2.3B | $2.4B | $1.2B | $1.1B | $1.2B |
| Margins | |||||||
| Gross margin | 43.0% | 42.8% | 41.8% | 40.2% | 37.6% | 38.0% | 38.7% |
| Operating margin | 2.5% | 4.0% | 4.6% | 3.7% | −18.9% | 0.1% | 2.0% |
| EBITDA margin | 6.4% | 7.5% | 7.6% | 6.9% | −15.6% | 3.5% | 5.3% |
| Net margin | −2.2% | −0.5% | 2.8% | 1.5% | −20.5% | −1.7% | 0.2% |
| FCF margin | −1.1% | 2.2% | 2.1% | 1.1% | −0.2% | 0.8% | 3.1% |
| Returns | |||||||
| Return on capital | — | 4.3% | 5.3% | 4.0% | −35.2% | 0.2% | 3.3% |
| Return on capital employed | — | 3.7% | 4.9% | 4.0% | −27.8% | 0.2% | 3.0% |
| Return on equity | −17.1% | −2.0% | 7.6% | 3.9% | −71.8% | −8.9% | 0.8% |
| Return on assets | — | −0.4% | 2.6% | 1.4% | −21.4% | −1.9% | 0.2% |
| Return on tangible equity | — | — | 182.6% | 48.4% | −627.1% | −76.2% | 4.9% |
| Growth | |||||||
| Revenue growth | — | 11.0% | 18.0% | 3.9% | 3.6% | −2.2% | −2.5% |
| Net income growth | — | — | — | −44.8% | −1,509.9% | — | — |
| EPS growth | — | — | — | −45.2% | −1,505.9% | — | — |
| FCF growth | — | — | 9.2% | −42.9% | −114.5% | — | 276.3% |
| Share count change | — | 0.9% | 25.9% | 100,145.4% | 0.6% | 2.2% | 4.7% |
| Financial health | |||||||
| Net debt / EBITDA | — | 4.2x | 3.4x | 3.5x | — | 6.6x | 3.9x |
| Debt / equity | — | 0.8x | 0.7x | 0.7x | 1.3x | 1.4x | 1.3x |
| Interest coverage | 0.4x | 0.9x | 3.4x | 2.2x | −7.8x | 0.0x | 0.9x |
| Current ratio | — | 0.9x | 1.0x | 1.0x | 0.9x | 0.9x | 0.9x |
| Quick ratio | — | 0.3x | 0.4x | 0.4x | 0.2x | 0.3x | 0.4x |
| Capital allocation | |||||||
| Capex / revenue | 3.5% | 3.2% | 4.1% | 4.6% | 3.6% | 2.1% | 2.1% |
| Stock comp / revenue | 0.2% | 0.3% | 0.8% | 1.0% | 1.3% | 0.8% | 0.5% |
| Quality scores | |||||||
| Piotroski F-score | — | — | 7.0 | 5.0 | 3.0 | 5.0 | 7.0 |
| Altman Z'' | — | 0.6 | 0.9 | 0.9 | −2.0 | −0.6 | −0.4 |
| Accruals ratio | — | −4.9% | −3.1% | −3.9% | −25.0% | −5.3% | −5.9% |
Source: SEC EDGAR XBRL filings (CIK 0001826470). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.